Familial adenomatous polyposis in children younger than age ten years: a multidisciplinary clinic experience

Thomas M Attard1, Tanya Tajouri, Kristin D Peterson

  • 1University of Nebraska Medical Center, Omaha, Nebraska 68198-5160, USA. tattard@unmc.edu

Insights

Familial adenomatous polyposis (FAP) in young children requires early surveillance. Children with the APC gene mutation at codon 1309 may need early colectomy due to aggressive disease.

Area of Science:

  • Pediatric Gastroenterology
  • Oncology
  • Genetics

Background:

  • Familial adenomatous polyposis (FAP) presents significant mortality and morbidity in children within their first decade.
  • Severe FAP phenotypes can manifest early with colorectal adenomas, potentially necessitating early colectomy.
  • Multidisciplinary care is crucial for managing FAP in pediatric populations.

Purpose of the Study:

  • To evaluate the clinical experience with familial adenomatous polyposis in children under ten years of age.
  • To analyze the demographics, clinical course, genetic mutations, and surgical outcomes in this pediatric cohort.
  • To identify risk factors for aggressive disease presentation in young FAP patients.

Main Methods:

  • Cross-sectional analysis of pediatric patients with suspected or confirmed FAP presenting before age ten.
  • Inclusion of demographic data, clinical presentation, gene mutation testing (APC gene), and endoscopic-histologic findings.
  • Assessment of surgical outcomes and correlation with specific APC gene mutations and de novo cases.

Main Results:

  • Twenty-two children were evaluated; two had negative APC gene mutation tests.
  • Hepatoblastoma surveillance showed negative findings in all patients through age ten.
  • APC gene mutation at codon 1309 and de novo FAP were associated with earlier colectomy referrals due to aggressive phenotypes.

Conclusions:

  • Children with FAP under age ten can present presymptomatically, highlighting the need for surveillance.
  • The APC gene mutation at codon 1309 indicates a higher risk of aggressive FAP phenotype.
  • Early colectomy may be indicated for pediatric FAP patients with the specific 1309 APC gene mutation.
Abstract

Related Concept Videos

Inflammatory Bowel Disease V: Surgical Management01:21

Inflammatory Bowel Disease V: Surgical Management

Surgical interventions for inflammatory bowel disease (IBD), which includes ulcerative colitis and Crohn's disease, are essential in managing symptoms and addressing complications. The selection of surgical procedures is contingent upon the specific conditions and complications that stem from these illnesses.
Here are some common surgical interventions for IBD:
Chronic Bowel Disorders: Introduction01:17

Chronic Bowel Disorders: Introduction

Chronic bowel diseases are a group of long-term conditions affecting the digestive tract, characterized by inflammation and damage to the gut lining. These conditions primarily include irritable bowel syndrome and inflammatory bowel disease.
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
Barrett Esophagus-II: Clinical Manifestations and Management01:21

Barrett Esophagus-II: Clinical Manifestations and Management

Individuals with Barrett's esophagus are often asymptomatic, but they may experience symptoms commonly associated with GERD, such as heartburn and acid regurgitation. Additional symptoms can include difficulty swallowing, chest pain, unintentional weight loss, blood in the stool (which may appear black, tarry, or bloody), and episodes of vomiting.
To diagnose Barrett's esophagus, healthcare providers often recommend an endoscopy for those showing symptoms of acid reflux. The procedure entails...
Cystic Fibrosis: Management01:24

Cystic Fibrosis: Management

Cystic fibrosis (CF) is an autosomal recessive disorder that predominantly affects individuals of Northern European descent, occurring at a rate of 1 in 3500. It is caused by a genetic mutation in a gene on chromosome 7, most commonly the ΔF508 mutation, that codes for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. This results in thicker mucus secretions and obstruction pathologies in multiple organs, including the lungs and sinuses.
Sinus disease and chronic sinusitis...